Conversely, studies have shown that both patients and healthcare professionals are reluctant to initiate GLP-1RAs [11, 12], despite the guideline recommendations and the health benefits of these therapies, particularly for patients in need of weight loss and those with low estimated glomerular filtration rate [1]
The extension covers four new strengths: 1.5 mg, 4 mg, 9 mg and 25 mg for oral use
This is a medication change that requires medical supervision, and here is how to have that conversation productively
The medication may trigger headaches indirectly by lowering blood sugar levels, dehydration, or vascular changes
This article breaks down how each drug works, what trials show so far, where they differ in side effects and heart health, and how to think about choosing between them
Many patients notice: Weight loss may begin during this stage, although the amount varies considerably from person to person